Diagnostic Efficacy of Serum 1,3-β-D-glucan for Invasive Fungal Infection: An Update Meta-Analysis Based on 37 Case Or Cohort Studies
- PMID: 30211316
- PMCID: PMC6132083
- DOI: 10.1515/med-2018-0050
Diagnostic Efficacy of Serum 1,3-β-D-glucan for Invasive Fungal Infection: An Update Meta-Analysis Based on 37 Case Or Cohort Studies
Abstract
Objective: The aim of this study was to investigate the diagnostic performance of serum 1,3-β-D-gluan as biomarker for invasive fungal infection through meta-analysis.
Methods: The electronic databases of Medline, Cochrane, Embase, Web of Science, OVID and CNKI were systematic searched to identified the case-control or Cohort studies relevant to diagnostic efficacy of serum 1,3-β-D-glucan for invasive fungal infection. The data of true positive (tp), false positive (fp), false negative (fn) and true negative (tn) patients number were extracted from each of the original included studies. The diagnostic sensitivity, specificity and systematic receiver operating characteristic (SROC) curve were calculated and pooled through random or fixed effect method. The publication bias was evaluated by the Deek's funnel plot.
Results: Thirty-seven relevant studies were fulfilled the inclusion criteria and included in our present meta-analysis. The combined sensitivity, specificity, positive likely hood ratio (+lr), negative likely hood ratio (-lr) and diagnostic odds ratio(dor) for 1,3-β-D-glucan in diagnosis of invasive fungal infectionwere 0.83 (95%CI:0.38-0.61), 0.81 (95%CI:0.80-0.82), 5.13 (95%CI:3.98-6.62), 0.23 (95%CI:0.18-0.30), and 29.68 (95%CI:18.94-46.52) respectively. The pooled area under the ROC curve (AUC) was 0.91.The Deek's funnel plot asymmetry test showed there was no publication bias for 1,3-β-D-glucan in diagnosis of invasive fungal infection of the included 37 studies.
Conclusion: Serum 1,3-β-D-glucan assay was a promising biomarker for invasive fungal infection diagnosis.
Keywords: 1,3-β-D-glucan; diagnosis; invasive fungal infection; meta-analysis.
Conflict of interest statement
Conflict of interest: The authors report no conflicts of interest in this work.
Figures










Similar articles
-
The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.J Cancer Res Ther. 2014 Nov;10 Suppl:C131-4. doi: 10.4103/0973-1482.145835. J Cancer Res Ther. 2014. PMID: 25450270
-
Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging for breast cancer detection: An update meta-analysis.Thorac Cancer. 2021 Dec;12(23):3201-3207. doi: 10.1111/1759-7714.14187. Epub 2021 Oct 20. Thorac Cancer. 2021. PMID: 34668649 Free PMC article.
-
APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.Thorac Cancer. 2021 Nov;12(21):2907-2913. doi: 10.1111/1759-7714.14151. Epub 2021 Sep 20. Thorac Cancer. 2021. PMID: 34545707 Free PMC article.
-
Metagenomics next-generation sequencing for the diagnosis of central nervous system infection: A systematic review and meta-analysis.Front Neurol. 2022 Sep 20;13:989280. doi: 10.3389/fneur.2022.989280. eCollection 2022. Front Neurol. 2022. PMID: 36203993 Free PMC article.
-
Diagnostic performance of the nerve root sedimentation sign in lumbar spinal stenosis: a systematic review and meta-analysis.Neuroradiology. 2019 Oct;61(10):1111-1121. doi: 10.1007/s00234-019-02248-3. Epub 2019 Jul 30. Neuroradiology. 2019. PMID: 31363807
Cited by
-
Microbiological Non-Culture-Based Methods for Diagnosing Invasive Pulmonary Aspergillosis in ICU Patients.Diagnostics (Basel). 2023 Aug 21;13(16):2718. doi: 10.3390/diagnostics13162718. Diagnostics (Basel). 2023. PMID: 37627977 Free PMC article. Review.
-
Role of (1-3)-Β-D-Glucan Test in the Diagnosis of Invasive Fungal Infections among High-Risk Patients in a Tertiary Care Hospital.J Lab Physicians. 2022 Feb 9;14(3):306-311. doi: 10.1055/s-0042-1742632. eCollection 2022 Sep. J Lab Physicians. 2022. PMID: 36119434 Free PMC article.
-
Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease.J Fungi (Basel). 2020 Dec 29;7(1):14. doi: 10.3390/jof7010014. J Fungi (Basel). 2020. PMID: 33383818 Free PMC article. Review.
-
A Diagnostic Stewardship Intervention to Improve Utilization of 1,3 β-D-Glucan Testing at a Single Academic Center: Five-Year Experience.Open Forum Infect Dis. 2024 Jul 1;11(7):ofae358. doi: 10.1093/ofid/ofae358. eCollection 2024 Jul. Open Forum Infect Dis. 2024. PMID: 39035574 Free PMC article.
References
-
- Martino R, Lopez R, Sureda A, Brunet S, Domingo-Albós A.. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature. Haematologica. 1997;82:297–304. - PubMed
-
- García-Ruiz JC, Amutio E, Pontón J.. Invasive fungal infection in immunocompromised patients. Rev Iberoam Micol. 2004;21:55–62. - PubMed
-
- Ibáñez-Martínez E, Ruiz-Gaitán A, Pemán-García J.. Update on the diagnosis of invasive fungal infection. Rev Esp Quimioter. 2017;30(1):16–21. - PubMed
-
- Onishi A, Sugiyama D, Kogata Y, Saegusa J, Sugimoto T, Kawano S, Morinobu A, Nishimura K, Kumagai S.. Diagnostic accuracy of serum 1, 3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol. 2012;50:7–15. - PMC - PubMed
-
- He S, Hang JP, Zhang L, Wang F, Zhang DC, Gong FH.. A systematic review and meta-analysis of diagnostic accuracy of serum 1, 3-β-D-glucan for invasive fungal infection: Focus on cutoff levels. J Microbiol Immunol Infect. 2015;48:351–361. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous